Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.

Sen A. et al, (2024), Epilepsia Open

The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.

Vasey MJ. et al, (2024), Epilepsia Open, 9, 1931 - 1947

Equitable access to levetiracetam for people with epilepsy.

Sen A. et al, (2024), Lancet Neurol

Baseline characteristics and predictors for early implantation of vagus nerve stimulation therapy in people with drug-resistant epilepsy: Observations from an international prospective outcomes registry (CORE-VNS).

Kwan P. et al, (2024), Epilepsia Open

Optogenetic Determination of Dynamic and Cell-Type-Specific Inhibitory Reversal Potentials.

Burman RJ. et al, (2024), J Neurosci, 44

Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE).

Costello DJ. et al, (2024), Epilepsia

Active cortical networks promote shunting fast synaptic inhibition in vivo.

Burman RJ. et al, (2023), Neuron

Optogenetic determination of dynamic and cell-type-specific chloride equilibrium potentials

Burman RJ. et al, (2023)

Analysing patient-generated data to understand behaviours and characteristics of women with epilepsy of childbearing years: A prospective cohort study.

Zhou S-M. et al, (2023), Seizure, 108, 24 - 32

Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control study.

Jones GD. et al, (2023), Lancet Digit Health, 5, e185 - e193

Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy

Perucca P. et al, (2023), Annals of Neurology, 93, 752 - 761

Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors.

Tai XY. et al, (2023), JAMA Neurol

Active cortical networks promote shunting fast synaptic inhibitionin vivo

Burman RJ. et al, (2023)

Current evidence for adjunct pyridoxine (vitamin B6) for the treatment of behavioral adverse effects associated with levetiracetam: A systematic review.

Besag FMC. et al, (2023), Epilepsy Behav, 140

Variation in access to specialist services for neurosurgical procedures in adults with epilepsy in England, a cohort study.

Murphy J. et al, (2022), Seizure

Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults.

Ferreira-Atuesta C. et al, (2022), Brain

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study.

Taquet M. et al, (2022), Neurology

Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults

Ferreira-Atuesta C. et al, (2022)

Inequalities in specialist care for people with epilepsy in the UK.

Pinho-Gomes A-C. et al, (2022), Lancet Neurol, 21, 504 - 505

Editorial: Epilepsy in older adults: From physiopathology to improvements in diagnosis and management.

Romigi A. et al, (2022), Front Neurol, 13

Load More

Include forthcoming?